347 related articles for article (PubMed ID: 28428185)
1. Investments in cancer research awarded to UK institutions and the global burden of cancer 2000-2013: a systematic analysis.
Maruthappu M; Head MG; Zhou CD; Gilbert BJ; El-Harasis MA; Raine R; Fitchett JR; Atun R
BMJ Open; 2017 Apr; 7(4):e013936. PubMed ID: 28428185
[TBL] [Abstract][Full Text] [Related]
2. Research Investments in Global Health: A Systematic Analysis of UK Infectious Disease Research Funding and Global Health Metrics, 1997-2013.
Head MG; Fitchett JR; Nageshwaran V; Kumari N; Hayward A; Atun R
EBioMedicine; 2016 Jan; 3():180-190. PubMed ID: 26870829
[TBL] [Abstract][Full Text] [Related]
3. UK investments in global infectious disease research 1997-2010: a case study.
Head MG; Fitchett JR; Cooke MK; Wurie FB; Hayward AC; Atun R
Lancet Infect Dis; 2013 Jan; 13(1):55-64. PubMed ID: 23140942
[TBL] [Abstract][Full Text] [Related]
4. Research investments for UK infectious disease research 1997-2013: A systematic analysis of awards to UK institutions alongside national burden of disease.
Head MG; Brown RJ; Clarke SC
J Infect; 2018 Jan; 76(1):11-19. PubMed ID: 29061335
[TBL] [Abstract][Full Text] [Related]
5. The allocation of USdollar;105 billion in global funding from G20 countries for infectious disease research between 2000 and 2017: a content analysis of investments.
Head MG; Brown RJ; Newell ML; Scott JAG; Batchelor J; Atun R
Lancet Glob Health; 2020 Oct; 8(10):e1295-e1304. PubMed ID: 32971052
[TBL] [Abstract][Full Text] [Related]
6. Investments in respiratory infectious disease research 1997-2010: a systematic analysis of UK funding.
Head MG; Fitchett JR; Cooke MK; Wurie FB; Hayward AC; Lipman MC; Atun R
BMJ Open; 2014 Mar; 4(3):e004600. PubMed ID: 24670431
[TBL] [Abstract][Full Text] [Related]
7. Comparing research investment to United Kingdom institutions and published outputs for tuberculosis, HIV and malaria: a systematic analysis across 1997-2013.
Head MG; Fitchett JR; Derrick G; Wurie FB; Meldrum J; Kumari N; Beattie B; Counts CJ; Atun R
Health Res Policy Syst; 2015 Nov; 13():63. PubMed ID: 26537547
[TBL] [Abstract][Full Text] [Related]
8. Systematic analysis of funding awarded for mycology research to institutions in the UK, 1997-2010.
Head MG; Fitchett JR; Atun R; May RC
BMJ Open; 2014 Jan; 4(1):e004129. PubMed ID: 24413353
[TBL] [Abstract][Full Text] [Related]
9. Funding infectious disease research: a systematic analysis of UK research investments by funders 1997-2010.
Fitchett JR; Head MG; Cooke MK; Wurie FB; Atun R
PLoS One; 2014; 9(8):e105722. PubMed ID: 25162631
[TBL] [Abstract][Full Text] [Related]
10. Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments.
McIntosh SA; Alam F; Adams L; Boon IS; Callaghan J; Conti I; Copson E; Carson V; Davidson M; Fitzgerald H; Gautam A; Jones CM; Kargbo S; Lakshmipathy G; Maguire H; McFerran K; Mirandari A; Moore N; Moore R; Murray A; Newman L; Robinson SD; Segaran A; Soong CN; Walker A; Wijayaweera K; Atun R; Cutress RI; Head MG
Lancet Oncol; 2023 Jun; 24(6):636-645. PubMed ID: 37269844
[TBL] [Abstract][Full Text] [Related]
11. A systematic analysis of UK cancer research funding by gender of primary investigator.
Zhou CD; Head MG; Marshall DC; Gilbert BJ; El-Harasis MA; Raine R; O'Connor H; Atun R; Maruthappu M
BMJ Open; 2018 Apr; 8(4):e018625. PubMed ID: 29712689
[TBL] [Abstract][Full Text] [Related]
12. Mapping pneumonia research: A systematic analysis of UK investments and published outputs 1997-2013.
Head MG; Fitchett JR; Newell ML; Scott JA; Harris JN; Clarke SC; Atun R
EBioMedicine; 2015 Sep; 2(9):1193-9. PubMed ID: 26501117
[TBL] [Abstract][Full Text] [Related]
13. Are the Norwegian health research investments in line with the disease burden?
Kinge JM; Roxrud I; Vollset SE; Skirbekk V; Røttingen JA
Health Res Policy Syst; 2014 Nov; 12():64. PubMed ID: 25427859
[TBL] [Abstract][Full Text] [Related]
14. An analysis of discrepancies between United Kingdom cancer research funding and societal burden and a comparison to previous and United States values.
Carter AJ; Delarosa B; Hur H
Health Res Policy Syst; 2015 Nov; 13():62. PubMed ID: 26526609
[TBL] [Abstract][Full Text] [Related]
15. Global public and philanthropic investment in childhood cancer research: systematic analysis of research funding, 2008-16.
Loucaides EM; Fitchett EJA; Sullivan R; Atun R
Lancet Oncol; 2019 Dec; 20(12):e672-e684. PubMed ID: 31797794
[TBL] [Abstract][Full Text] [Related]
16. Infectious disease research investments: systematic analysis of immunology and vaccine research funding in the UK.
Fitchett JR; Head MG; Atun R
Vaccine; 2013 Dec; 31(50):5930-3. PubMed ID: 24176489
[TBL] [Abstract][Full Text] [Related]
17. National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme research funding and UK burden of disease.
Chinnery F; Bashevoy G; Blatch-Jones A; Douet L; Puddicombe S; Raftery J
Trials; 2018 Feb; 19(1):87. PubMed ID: 29394905
[TBL] [Abstract][Full Text] [Related]
18. Discrepancies between Canadian cancer research funding and site-specific cancer burden: a spotlight on ten disease sites.
Coronado AC; Finley C; Badovinac K; Han J; Niu J; Rahal R
Curr Oncol; 2018 Oct; 25(5):338-341. PubMed ID: 30464683
[TBL] [Abstract][Full Text] [Related]
19. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions.
Soerjomataram I; Lortet-Tieulent J; Parkin DM; Ferlay J; Mathers C; Forman D; Bray F
Lancet; 2012 Nov; 380(9856):1840-50. PubMed ID: 23079588
[TBL] [Abstract][Full Text] [Related]
20. To what extent is health and medical research funding associated with the burden of disease in Australia?
Aoun S; Pennebaker D; Pascal R
Aust N Z J Public Health; 2004 Feb; 28(1):80-6. PubMed ID: 15108752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
